Integrin-based therapeutics: biological basis, clinical use and new drugs
K Ley, J Rivera-Nieves, WJ Sandborn… - Nature reviews Drug …, 2016 - nature.com
Integrins are activatable molecules that are involved in adhesion and signalling. Of the 24
known human integrins, 3 are currently targeted therapeutically by monoclonal antibodies …
known human integrins, 3 are currently targeted therapeutically by monoclonal antibodies …
Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
The article describes the mechanisms of action, pharmacokinetics, and pharmacodynamics
of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein IIb/IIIa …
of aspirin, dipyridamole, cilostazol, the thienopyridines, and the glycoprotein IIb/IIIa …
[HTML][HTML] Pathophysiology and diagnosis of drug-induced immune thrombocytopenia
C Vayne, EA Guéry, J Rollin, T Baglo… - Journal of clinical …, 2020 - mdpi.com
Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …
Idiosyncratic adverse drug reactions: current concepts
J Uetrecht, DJ Naisbitt - Pharmacological reviews, 2013 - ASPET
Idiosyncratic drug reactions are a significant cause of morbidity and mortality for patients;
they also markedly increase the uncertainty of drug development. The major targets are skin …
they also markedly increase the uncertainty of drug development. The major targets are skin …
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
This article discusses platelet active drugs as part of the Seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …
Drug-induced immune thrombocytopenia
RH Aster, DW Bougie - New England Journal of Medicine, 2007 - Mass Medical Soc
Drug-induced thrombocytopenia should be suspected in any patient with acute
thrombocytopenia of unknown cause. Although the incidence is low, more than 100 drugs …
thrombocytopenia of unknown cause. Although the incidence is low, more than 100 drugs …
Integrins: dynamic scaffolds for adhesion and signaling in platelets
SJ Shattil, PJ Newman - Blood, 2004 - ashpublications.org
The major platelet integrin, αIIbβ3, is required for platelet interactions with proteins in plasma
and the extracellular matrices (ECMs) that are essential for platelet adhesion and …
and the extracellular matrices (ECMs) that are essential for platelet adhesion and …
[HTML][HTML] Integrins as therapeutic targets: successes and cancers
S Raab-Westphal, JF Marshall, SL Goodman - Cancers, 2017 - mdpi.com
Integrins are transmembrane receptors that are central to the biology of many human
pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with …
pathologies. Classically mediating cell-extracellular matrix and cell-cell interaction, and with …
Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines
This article about currently available antiplatelet drugs is part of the Antithrombotic and
Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical …
Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical …
[HTML][HTML] Structure and function of the platelet integrin αIIbβ3
JS Bennett - The Journal of clinical investigation, 2005 - Am Soc Clin Investig
The platelet integrin αIIbβ3 is required for platelet aggregation. Like other integrins, αIIbβ3
resides on cell surfaces in an equilibrium between inactive and active conformations …
resides on cell surfaces in an equilibrium between inactive and active conformations …